Inventor
LAWRENCE SHAWN
US18 patents
⚠️ This page may combine multiple inventors who share the name “LAWRENCE SHAWN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
REGENERON PHARMA
14 patentsUS11548932B2Jan 10, 2023
Anti-VEGF protein compositions and methods for producing the same
REGENERON PHARMA8 citations93
US11535663B2Dec 27, 2022
Methods for producing aflibercept in chemically defined media having reduced aflibercept variants
REGENERON PHARMA6 citations93
US10927342B2Feb 23, 2021
Taurine supplemented cell culture medium and methods of use
REGENERON PHARMA23 citations92
US11472861B2Oct 18, 2022
Methods for producing aflibercept in chemically defined media having reduced aflibercept variants
REGENERON PHARMA5 citations91
US11104715B2Aug 31, 2021
Methods for producing aflibercept in chemically defined media having reduced aflibercept variants
REGENERON PHARMA5 citations91
US12012445B2Jun 18, 2024
Anti-VEGF protein compositions and methods for producing the same
REGENERON PHARMA4 citations85
US11505594B2Nov 22, 2022
Anti-VEGF protein compositions and methods for producing the same
REGENERON PHARMA1 citations83
US11312936B2Apr 26, 2022
Taurine supplemented cell culture medium and methods of use
REGENERON PHARMA1 citations71
US11390663B2Jul 19, 2022
Metabolically optimized cell culture
REGENERON PHARMA1 citations66
US12359166B2Jul 15, 2025
Taurine supplemented cell culture medium and methods of use
REGENERON PHARMA0 citations60
US12359165B2Jul 15, 2025
Taurine supplemented cell culture medium and methods of use
REGENERON PHARMA0 citations60
US12221619B2Feb 11, 2025
Taurine supplemented cell culture medium and methods of use
REGENERON PHARMA0 citations60
US12545717B2Feb 10, 2026
Metabolically optimized cell culture
REGENERON PHARMA0 citations56
US12291563B2May 6, 2025
Metabolically optimized cell culture
REGENERON PHARMA0 citations56